SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Filings re: Registrant of ‘8-K’ Filing 1493152-20-5788


        

1,394  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   70   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
 4/29/24  Cicala Peter                      4          Director²   1:5K   Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
 4/29/24  Gurrola Sandra M                  4          Officer²    1:5K   Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
 4/29/24  Bristol James Arthur              4          Director²   1:5K   Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
 3/22/24  Eterna Therapeutics Inc.          8-K:3       3/19/24   10:153K                                   Broadridge Fin’l So… Inc 
 3/18/24  Eterna Therapeutics Inc.          10-K/A     12/31/23   13:247K                                   Broadridge Fin’l So… Inc 
 3/14/24  Eterna Therapeutics Inc.          10-K       12/31/23  108:11M                                    Broadridge Fin’l So… Inc 
 2/16/24  Cicala Peter                      3          Director²   2:11K  Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
 2/16/24  Eterna Therapeutics Inc.          8-K:5       2/12/24   10:154K                                   Broadridge Fin’l So… Inc 
 1/31/24  Halpern John D                    SC 13G/A               2:68K  Eterna Therapeutics Inc.          Donnelley … Solutions/FA 
          Katherine H. Halpern³
 1/24/24  Eterna Therapeutics Inc.          424B3                  1:207K                                   Broadridge Fin’l So… Inc 
 1/22/24 Eterna Therapeutics Inc.          EFFECT      1/22/24    1:2K                                     SEC #5                   
 1/19/24  Eterna Therapeutics Inc.          8-K:3       1/17/24   10:153K                                   Broadridge Fin’l So… Inc 
 1/19/24  Singer Nicholas Jason             SC 13G/A               1:59K  Eterna Therapeutics Inc.          EdgarAgents LLC/FA       
          Purchase Capital LLC³
 1/18/24  Eterna Therapeutics Inc.          CORRESP2/21/24    1:7K                                     Broadridge Fin’l So… Inc 
 1/17/24  SEC                               UPLOAD2/21/24    2:40K  Eterna Therapeutics Inc.                                   
 1/16/24  Eterna Therapeutics Inc.          S-8         1/16/24    6:412K                                   Broadridge Fin’l So… Inc 
 1/12/24  Eterna Therapeutics Inc.          S-3                    5:426K                                   Broadridge Fin’l So… Inc 
  1/3/24  Luther Sanjeev                    4          Dir.,Off.²  1:5K   Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
  1/3/24  Clarke Dorothy J                  4          Dir.,Off.²  1:5K   Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
  1/3/24  Luther Sanjeev                    3          Dir.,Off.²  2:13K  Eterna Therapeutics Inc.          Broadridge Fin’l So… Inc 
____________
 ‡  A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm
Five-thirty emoji
ET
.  The legal “Filed As Of” date may be the next, or another, day.
 ¹  Filing/Form Types: 
Type emoji
/A
  3    Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
  4    Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  10-K    Annual Report — Form 10-K.
  424B3    Prospectus – New Facts or Events.
  CORRESP    Comment-Response or Other Letter to the SEC.
  EFFECT    SEC Notice of Effectiveness.
  S-3    Registration Statement – Securities for a Transaction — Form S-3.
  S-8    Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
  SC 13G    Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
  UPLOAD    Comment or Other Letter from the SEC.
  /A  Amendment to, or Amended version of, a previous Filing of this Type.
  ¶  This Filing contains a delayed-release Document.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
 ³  Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.
 
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   70   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 1:27:59.5pm ET